Clinical trial
Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are…
NCT00052221 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00052221 |
|---|---|
| Title | Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy |
| Official title | A Placebo Controlled Trial Of Short-Term, High-Dose Epoetin Alfa In Advanced Cancer Outpatients With Mild Fatigue |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Other |
| Interventions | Epoetin alfa, Placebo |
| Enrollment | 0 |
| Start date | May 20, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 8, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: